Moderna, Caris Life Team Up to Advance mRNA-Based Oncology Therapeutics

Moderna and Caris Life Sciences on Tuesday said they entered a multi-year strategic partnership to work on advancing mRNA-based oncology therapeutics.

The agreement will allow Moderna to utilize Caris' library of "de-identified, multi-modal data and analytics capabilities to accelerate precision medicine and the delivery of novel medicines to patients," the companies said.